On the 1,273rd day of the global pandemic, several high-profile figures including Jill Biden and Whoopi Goldberg have contracted the SARS-CoV-2 virus while the rising cases of the virus continue to cause distress. Simultaneously, both the EU and UK separately authorized the modified Pfizer-BioNTech vaccine for usage amid significant public apprehension.
New research in the New York Times introduces an overlooked issue: Long Covid and senior citizens. It suggests the existence of ‘special challenges’ faced by elderly patients who contract Covid-19 and notably identifies four symptom clusters in this demographic – metabolic disorders, cardiovascular problems, gastrointestinal issues, and neurological symptoms.
Another emergent study from JAMA Oncology questions the disparity in Covid-19 mortality rates among those with cancer, compared to the general population, during the Omicron wave. The findings imply a ‘disparate burden’ faced by cancer patients, underscoring the necessity to enhance strategizing against Covid-19 transmission especially as new variants arise.
A burdensome controversy now lies in the consideration by the Centers for Disease Control and Prevention (CDC) and its Healthcare Infection Control Practices Advisory Committee to relax infection control guidelines within hospital settings. Healthcare providers are responding with alarm, given the ever-increasing cases.
Given the situation, restrictions on alcohol consumption in the country are also coming into focus. White House press secretary Karine Jean-Pierre was caught off guard when asked about a potential limit on the number of alcoholic beverages Americans should consume per week.
The Omicron subvariant BA.2.86 is currently in scrutiny. It carries more than 30 mutations, forming an evolutionary leap reminiscent of the original Omicron variant. However, despite it being highly mutated, preliminary studies confirm that it may not escalate the level of contagion or evade immunity as feared earlier.
Methods of Covid-19 testing and prevention are evolving concurrently. In New York State, home-based Covid-19 tests and high-quality face masks are now available via schools. The state is also launching a subvariant BA.2.86 detection initiative via wastewater analysis.
The Pfizer-BioNTech vaccine has been updated to target the currently dominant XBB.1.5 subvariant of Omicron and has received regulatory approval in the EU and UK for usage in adults and children, with doses varying based on patient’s prior vaccination history.
Despite encouraging vaccine statistics, a large population globally from low-income countries hasn’t received even a single dose of the vaccine. Relevant American data from August 5, 2023, states 152.51 million updated bivalent doses administered in the country, with the vaccination threshold at least one dose at 81.4%. However, less than 33% from poorer countries have had one dose, and worse, several countries like Haiti, Senegal, and Tanzania exhibit vaccination rates at or under 10%.
In conclusion, despite encouraging strides in virus containment and management, the ongoing pandemic continues to pose a significant threat, particularly to vulnerable and disadvantaged populations. Policymakers must thus remain vigilant and prioritise risk mitigation, especially as new variants continue to emerge.
Source: https://www.frequentbusinesstraveler.com/2023/09/coronavirus-morning-news-brief-sept-5-jill-biden-and-whoopie-goldberg-tests-positive-for-covid-eu-and-uk-approve-updated-pfizer-vaccine/